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Abstract
The following chapter provides a brief overview on the prevalence, clinical features, 
and histological findings in chronically occluded coronary arteries. The role of coronary 
collaterals and myocardial viability as well as left ventricular function for the evalua-
tion of treatment strategies of chronic total occlusions (CTO) will be discussed. Imaging 
modalities such as computed tomography and intracoronary imaging are discussed for 
their significance in CTO assessment and intervention. Finally, important clinical and 
procedural aspects, latest interventional strategies and techniques, the armamentarium 
of dedicated tools for CTO interventions, as well as evidence from published trials and 
clinical research in the field will be presented.
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1. Introduction
A chronic total occlusion (CTO) of a coronary artery is defined as complete closure of the 
vessel lumen for at least 3 months (Figure 1). The true prevalence of CTOs in the general 
population is unknown and assumed to be around 15–20% [1–3] but varies widely (30–50%) 
in patients with significant coronary artery disease (CAD) [1–5].
Percutaneous coronary intervention (PCI) of CTOs is considered to be the most challenging 
procedure in interventional cardiology and is associated with higher periprocedural failure 
and complication rates. At this, the presence of a CTO influences treatment recommendations 
and is a strong predictor against PCI as a treatment strategy [5].
CTO PCI in specialized centers is currently performed with success rates greater than 80% 
and decreasing complication rates, suggesting a favorable risk/benefit ratio supporting its 
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increasing selection as a treatment option [6]. However, discrepant CTO PCI quantity and 
success rates exist among catheterization laboratories [1] and may be explained by individual 
skills among operators, lesion assessment, and the absence of consensual treatment strategies. 
Recently, CTO PCI has become more predictable as a consequence of dedicated tools, stan-
dardized procedural techniques, and continuous educational programs.
Contemporary PCI strategies with dedicated devices significantly improved procedural suc-
cess, and the introduction of drug-eluting stents (DES) led to better long-term patency with 
preservation of left ventricular (LV) function. Still, there is little systematic evidence that post-
procedural outcomes have relevantly changed, although much retrospective data suggest 
CTO PCI as favorable.
2. Basics of chronic total occlusions
2.1. Definition
A “true” total occlusion is defined as a coronary lesion with thrombolysis in myocardial 
infarction (TIMI) flow grade 0. In order to be classified as “chronic,” the occlusion needs to 
be present for at least 3 months. It is difficult in clinical practice to determine the period of 
time for which a total occlusion has been present. The age of the occlusion is usually speci-
fied by detailed assessment of medical history and cardiovascular symptoms over the past 3 
months [7–9]. Despite using contemporary criteria for CTO, Fefer et al. reported determined 
CTO duration in only 46% of cases, whereas another recent survey showed a known occlu-
sion duration in 61% of CTO cases, with the undetermined duration of CTO as a predictor of 
procedural failure and major adverse cardiac events (MACE) [1, 10].
Figure 1. Stenosis versus chronic total occlusion.
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2.2. Prevalence and clinical features
In a recent report from the Canadian multicenter CTO registry, about 15% of patients with-
out previous coronary artery bypass graft (CABG) surgery or known CAD and about 18% of 
patients with clinically significant CAD show at least one CTO on coronary angiogram [9]. 
In these registries, only 40% had a prior history of myocardial infarction (twice as high as 
without CTO), and more than 50% of CTO patients showed normal LV ejection fraction [11]. 
Furthermore, 64% of these patients underwent medical therapy, 26% were referred to CABG 
(with 88% successfully bypassing CTO), and only 10% underwent PCI of the CTO [1, 9]. 
In this study, only 5% of patients with a CTO were asymptomatic and it was in general dif-
ficult to attribute symptoms to the CTO in symptomatic multi-vessel disease (MVD) cases. 
Interestingly, recanalization of an occluded left anterior descending artery (LAD) rather than 
PCI of an occluded right coronary artery (RCA) results in greater increase of left ventricular 
function and more beneficial autonomic nervous system parameters with a potential antiar-
rhythmic effect [12].
Patients with CAD and CTO are mostly men, tend to be older, and usually have a higher car-
diac risk profile. Interestingly, peripheral artery disease was found to be the strongest clinical 
predictor for the presence of a CTO [5]. In comparison to men, females with CTO tend to have 
less vessel disease, are usually older, have a higher frequency of hypertension and diabetes, 
and smoke less, but overall sex has no influence on CTO PCI failure [9, 13].
2.3. Spatial distribution of CTO
Few prospective surveys and a report from the National Heart, Lung, and Blood Institute 
(NHLBI) Dynamic Registry show CTO located in the RCA in over 50% of the cases [1, 14]. 
These figures are consistent with the Canadian multicenter CTO registry report, where, in 
most of the cases, CTO was found in the RCA (47%), 20% in the LAD, 16% in the left circum-
flex (LCX), and 17% in multiple locations [1, 9]. In a recent post-mortem analysis in CTO 
with and without CABG, CTO was most frequently located in the RCA (57.9%), followed by 
the LAD (22.1%) and LCX (20.0%), mainly located in the proximal segment (68.4%) of the 
vessel [15].
Garcia et al. examined the clinical and angiographic characteristics as well as clinical out-
comes of >1300 consecutive CTO PCIs prospectively and retrospectively in multiple centers in 
the US. The study showed that proximal lesions were more common, and these patients had a 
higher prevalence of adverse comorbidities, mostly heart failure with reduced left ventricular 
ejection fraction (LVEF). Furthermore, proximal lesions had more adverse angiographic fea-
tures (including proximal cap ambiguity, side branch at proximal cap, blunt or no stump, and 
moderate or severe calcification) but had more interventional collaterals and showed a higher 
angiographic complexity, resulting in longer and more complex procedures. The retrograde 
approach was used in half of the cases involving proximal CTO lesions and was successful in 
one-third of these cases. Surprisingly, procedural success and complication rates were similar 
to mid- and distal lesions [16].
Chronic Total Occlusions
http://dx.doi.org/10.5772/68067
45
3. Histopathology
Wang et al. demonstrated that acute coronary occlusions leading to segment elevation myo-
cardial infarction (STEMI) seem to predominately occur in predictable spots within the prox-
imal third of the coronary arteries and that for each 10 mm increase in distance from the 
ostium, the risk of an acute coronary occlusion significantly decreased by 13–30%, depending 
on the coronary vessel [17].
In contrast to this, sparse information exists concerning the genesis of CTO and its regional 
distribution in terms of recanalization. In some publications, soft plaque rupture during acute 
coronary syndrome (ACS) with rapid thrombotic occlusion followed by its organization is 
described as the main cause of CTO and only a few appear to derive from atheroma progres-
sion [18]. Furthermore, it seems that once thrombotic occlusion occurs the thrombus tends to 
disseminate retrograde from the site of occlusion to the proximal segments of the vessel with a 
major side branch [19]. It is known that due to increased chronic hypoxic induction of neovas-
culature, the affected vessel segment stays biologically active and shows a marked heteroge-
neity in compensatory angiogenesis with an unpredictable wide range of coronary collateral 
circulation [20].
3.1. Collaterals and microchannels in CTO
Successful guidewire crossing may be facilitated by the presence of intravascular microchan-
nels, but structural changes over time with variable localization of these microvessels are not 
well understood in terms of CTO recanalization [21].
In a post-mortem study of 96 CTO lesions, 49% exhibited residual <99% lumen stenosis by 
histologic criteria despite angiographically documented total occlusions [22]. In this cohort, 
adventitia and intimal plaque of total occlusions were the prevalent zones of inflammation 
and neovascularization. Furthermore, the results revealed in CTOs of all ages a close relation 
between cellular inflammation and vessel wall neovascularization in terms of location and 
intensity with an increase in numbers of neovascular channels rather than with an increase 
in their size.
Munce et al. found two histological types of microvessels in a rabbit model with induced 
femoral occlusion: a circumferentially oriented “extravascular” and a longitudinally oriented 
“intravascular” one. Interestingly, extravascular vessels around the occluded artery devel-
oped to a maximum at an early time point, followed by a slow regression over time, while 
intravascular vessel formation within the central body of the occlusion was delayed, and these 
vessels became thinner and more tortuous over time. Strongly angulated connections between 
the intra and extravascular microvessels were constantly present, which could explain devia-
tion of the guidewire into extravascular channels during CTO recanalization [21].
Katsuragawa et al. found different histomorphological features in CTOs with tapering of the 
proximal occlusion point compared to those with a blunt proximal cap [19]. A total of 80% 
of the tapering-type lesions had shorter occluded segments and showed small  recanalized 
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areas with surrounding loose fibrous tissue along the occluded segment. In lesions with a 
blunt proximal cap, recanalization was rare, and a side branch was frequently found prox-
imal to the occluded segment and easily entered by the guidewire, instead of the occlu-
sion. These features influence penetration of the proximal cap and crossing of the guidewire 
through the occluded segment and explain why the tapering type of occlusion is favorable 
for angioplasty.
3.2. Remodeling in CTO
As atherosclerotic lesions develop in arteries, two types of remodeling can occur [23]. Positive 
remodeling is a compensatory process in which the arterial wall grows outward in an attempt 
to maintain a constant lumen diameter. Negative remodeling is angiographically defined as 
the ratio of the occluded vessel diameter to the diameter of the contiguous normal vessel <1 
and was found to be the strongest predictor of failed antegrade CTO PCI [24, 25]. In negative 
remodeling, an early phase where fibrin-rich organizing thrombus becomes a proteoglycan-
rich thrombus and a late phase where proteoglycan-rich thrombus within the CTO body is 
replaced by dense collagen, thus complicating antegrade wiring, were found [15].
4. Coronary collaterals
Collaterals are interarterial connections that exist during prenatal development of the cor-
onary circulation and regress in most individuals [26]. They develop in a native occluded 
vessel through positive remodeling. With the low postocclusive pressure regions being 
interconnected by collateral vessels, pressure gradient along the occluded segment causes 
pulsatile shear stress and activates proliferation of vascular smooth muscle and endothelial 
cells. A complex interplay of actin-binding proteins, integrins and connexions, transcription 
factors, and mitogen-activated kinases finally leads to an increase in vascular diameter and 
tissue mass (positive remodeling), but still, the degree of functional restoration of blood flow 
capacity remains incomplete and ends at approximately 30% of maximal conductance in coro-
nary vessels [27, 28].
The diameter of interarterial connections is usually below the spatial resolution of modern 
digital angiographic imaging systems (>200 μm) and ranges between 40 and 200 μm. Most of 
these connecting microvessels have been observed to be located intramyocardially, and only 
few reach the size of coronary side branches well above 1 mm in diameter [29].
It seems that occluded coronary arteries do not exclusively determine the level of functional 
collateral flow capacity and that some individuals without stenotic lesions do have immedi-
ately recruitable collateral flow to prevent myocardial ischemia during a brief coronary occlu-
sion [30]. However, in patients without well-developed pre-existing interarterial connections, 
collaterals require between 2 and 12 weeks to fully reach functional capacity [31]. After suc-
cessful CTO PCI, collateral function usually regresses in collaterals with small diameters but 
has the potential to recover in case of reocclusion [32].
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4.1. Classification of collaterals in CTO
In 1985, Rentrop et al. developed an angiographic grading system to rate the effect of 
collaterals in filling the occluded arterial segment [33]. It distinguishes four degrees of 
collateral recipient artery filling by radiographic contrast medium, but in CTO with well-
developed, spontaneously visible collaterals, it lacks further differentiation because most 
collaterals are Rentrop grade 3 (complete epicardial filling by collateral vessel of the tar-
get artery). The Werner classification adds an additional parameter to describe spontane-
ously visible collaterals and demonstrates a close association with clinical determinants 
of collateral adequacy [31]. Werner et al. graded collateral connections (CC) according to 
the angiographic visibility: CC0: no continuous connection between donor and recipient 
artery, CC1: continuous, thread-like connections ( ≥0.4 mm), and CC2: continuous, small 
side branch-like size of the collateral throughout its course (>1 mm). These CC grades 
are more practical to determine interventional collaterals suitable for retrograde CTO 
PCI (Figure 2).
Figure 2. Interventional collaterals according to the Werner classification.
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4.2. Assessment of collateral function
Generally, collateral circulation in CTO is predominantly systolic and provides only 
approximately 50% of antegrade coronary flow, which itself is predominantly diastolic [34]. 
The assessment of collateral function in CTOs has a different quality than in nonoccluded 
lesions. Collateral blood pressure distal of a chronic occluded vessel is assessed by placing a 
piezo-resistive transducer beyond the occlusion, while the antegrade flow has not yet been 
re-established. This can be ensured by passing occlusive microcatheters over a recanalization 
guidewire and then exchanged for the pressure wire [29].
4.2.1. Collateral flow index (CFI)
Intracoronary (IC) flow velocity or pressure measurements to determine collateral flow is 
theoretically based on the fact that velocity or perfusion pressure signals with values above 
central venous pressure (CVP) obtained distal to an occluded vessel originates from collat-
erals [35]. Measurement of such signals provides the variables for the calculation of a CFI, 
which expresses the amount of flow via collaterals to the vascular region of interest as a 
fraction of the flow via the normally patent vessel. In contrast to qualitative assessment of 
collaterals, such as ST-segment changes and chest pain during PCI or the degree of collateral 
circulation on angiogram prior to PCI, intravascular flow velocity and pressure determina-
tion precisely reflect collateral blood flow. Approximately one-third of collateral flow to the 
occluded area relative to the patent vessel flow is needed to prevent myocardial ischemia at 
rest [28]. Noteworthy, the majority of patients with MI do not have enough of the collateral 
flow to avoid ischemia during coronary occlusion [36] and only 10% seem to have a recruit-
able CFI ≥ 0.4 [36]. Insufficient collateral flow indicated by a CFI ≤ 0.25 independently pre-
dicts long-term cardiac mortality [37], and only 10% seems to have a recruitable CFI ≥ 0.4 [36]. 
Above that, individuals with CTOs tend to have a higher CFI than those without, and the area 
at risk of myocardial infarction seems to be significantly associated with CFI.
4.2.2. Fractional flow reserve in the donor artery and coronary steal
Microvascular vasodilation might lead to reduced collateral blood flow during physical or 
pharmacological provocation in individuals with collateral-dependent blood supply. In order 
to generate coronary steal, Werner et al. describes, in reference to Gould et al., the following 
assumption: epicardial stenosis of the donor artery causes a pressure drop proximal to the 
collateral origin; the collateral resistance is significant, and the microvasculature distal to the 
occlusion lacks a vasodilatory reserve due to being already maximally dilated [38].
Therefore, Werner et al. measured fractional flow reserve in the donor artery (FFRD) at the ori-gin of the collaterals in patients with CTO and recorded coronary flow velocity and pressure 
during recanalization. Patients with steal had more severe regional dysfunction and those 
with steal but without an FFRD < 0.8 tended to have an impaired microvascular function. The authors concluded that coronary steal mainly occurs as a result of hemodynamically 
significant donor artery lesions and might have an adverse effect on the preservation of myo-
cardial function by collaterals.
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In 50 patients who successfully underwent CTO recanalization compared to 50 matched non-
CTO PCI subjects, patients with CTO and an intermediate donor artery stenosis showed a low 
FFRD with a high frequency of ischemia in the donor artery territory, which was often nor-malized by successful CTO treatment, thus suggesting recanalization of CTO as a preferred 
therapeutic strategy. Reference: CCI 2014.
5. Myocardial viability and left ventricular function
It is in general difficult to predict which patient with stable ischemic heart disease will receive 
interventional or surgical revascularization in the long term, after initially being treated 
with optimal medical therapy (OMT). In the occluded artery trial (OAT), late opening of 
infarct-related arteries (IRA) post-MI in stable patients with persistent total occlusion and 
no severe inducible ischemia showed no difference in rates of reinfarction, death, or severe 
heart failure compared to OMT [39]. Nevertheless, the results of OAT in terms of CTO have 
to be interpreted with caution because total occlusions in this trial were subacute (3–28 days, 
median 8 days) and therefore did not meet the CTO definition of at least a 3-month dura-
tion. Furthermore, patients in OAT showed a relatively normal baseline LVEF of 48% and 
were rather asymptomatic, whereas CTOs considered for PCI should be symptomatic or have 
proof of ischemia and viability [40].
An ischemic burden above 12.5% favors PCI in patients with CTO undergoing pre- and post-
interventional myocardial perfusion imaging, whereas subjects with mild pre-procedural 
ischemia (<6.25% of LV myocardium) tend to have increased ischemic burden after PCI [41]. 
Another magnetic resonance imaging (MRI) study significantly revealed reduction in induc-
ible perfusion defects and improvement in segmental myocardial viability by successful 
CTO PCI compared to unsuccessful revascularization [42]. Furthermore, successful CTO PCI 
increases hyperemic and resting myocardial blood flow with enhanced regional contractility 
already 24 h after the procedure [43]. Patients with an infarction and a transmural involve-
ment < 25% assessed by MRI show significant improvements in segmental wall thickening 
and a reduction of mean end-systolic and end-diastolic volumes after CTO PCI [44]. Finally, 
the diagnostic accuracy of pre-procedural contrast enhanced MRI in patients with CTO to 
detect myocardial infarction and to predict improvement of myocardial function after revas-
cularization seems to be better by using a combined viability analysis rather than focusing on 
the widely used transmural extent of infarction [45].
6. Coronary computed tomography angiography
Coronary computed tomography angiography (CTA) is increasingly used to diagnose CAD 
and shows potential in predicting the probability of procedural success and clinical benefit 
in CTO PCI [46, 47]. In contrast to invasive coronary angiography, CTA offers better quan-
tification of anatomical and morphological features in occluded vessels, especially in long 
lesions with pronounced tortuosity, and usually visualizes distal coronary segments more 
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precisely [48]. There are a number of CTA characteristics in CTO lesions to predict PCI failure. 
Some report calcifications >50% of the cross-sectional vessel area alone [49] or in combination 
with an occlusion length of >15 mm to be independent predictors of unsuccessful recanaliza-
tion [50], while others revealed the ratio of calcification over the cross-sectional vessel area as 
being predictive for procedural failure [51]. Moreover, marked vessel tortuosity at the occlu-
sion site seems to independently predict unsuccessful guidewire crossing [24] and multiple 
occlusions might have an adverse effect on revascularization’s outcome, as reported from the 
CT-Registry of Chronic Total Occlusion Revascularization (CT-RECTOR), probably due to 
reduced feasibility in guiding the wire through the multiple entry and exit points [46].
Conclusively, CTA features in CTO, as described above, may be applicable to assess severity 
of the occlusion and to predict PCI outcome in order to guide treatment decision, especially 
in complex lesions.
7. Imaging in CTO
CTO interventions are technically challenging due to limitations in visualizing occluded 
arteries by angiography. As mentioned before, ambiguous proximal CTO cap, side branch at 
the occlusion site, extended tortuosity, or heavy calcification with limited visibility of distal 
path are important angiographic features which increase procedural difficulties during CTO 
recanalization [7]. Multislice computed tomography (MSCT) can provide useful pre-proce-
dural information on the dimension of vessel calcification or tortuosity along the occluded 
segment but does not offer direct guidance during the procedure. Intravascular ultrasound 
(IVUS) and optical coherence tomography (OCT) can add visual guidance during CTO PCI to 
improve procedure time, safety, and efficacy.
7.1. Intravascular ultrasound
In contrast to OCT, IVUS can be operated in occluded vessels throughout the whole interven-
tional procedure. It is used to identify the best wire entry point for penetration of proximal 
fibrous cap or to visualize the guidewire to check intraluminal position before balloon angio-
plasty or stent deployment.
The IVUS probe is usually advanced into a side branch originating proximal to the occlusion 
to determine the vessel course within the CTO segment [52]. Standard IVUS catheters cannot 
generate information of the vessel distal of the occlusion, and their use is limited by the diam-
eter and angulation of side branches [53].
Besides its antegrade applications, IVUS is used in retrograde procedures to guide retrograde 
guidewire crossing and reverse controlled retrograde tracking techniques such as reverse 
CART to improve success rate and limit complications [52]. Generally, when using the retro-
grade approach in longer CTO lesions, IVUS guidance can reduce the incidence of subintimal 
wiring with consecutive side branch loss after stenting, angiographic extravasation, coronary 
hematoma, and perforation [54, 55].
Chronic Total Occlusions
http://dx.doi.org/10.5772/68067
51
Furthermore, the incidence of restenosis [56] or stent thrombosis after DES implantation [57] 
is related to minimum stent area detected by IVUS and malapposition due to aneurysm for-
mation after subintimal DES implantation during CTO PCI, and it can be optimized with the 
help of IVUS [55].
Although IVUS facilitates CTO PCI and has the potential to reduce periprocedural complica-
tions, the clinical benefit of IVUS-guided CTO PCI has not yet been proven, and further stud-
ies are needed [52].
7.2. Optical coherence tomography
OCT is more sensitive than IVUS in detecting coronary dissection during PCI and improves 
stent deployment or detection of acute complications. Furthermore, resolution of OCT is high 
enough to visualize microvessels, the different layers of the vessel wall, and even collagen 
concentration in coronary arteries [58].
In contrast to IVUS, conventional OCT, at the cost of penetration depth, has a 10-fold higher 
imaging resolution as the main advantage but is unable to generate images in completely 
occluded vessels and does not allow real-time intracoronary imaging for guidance of wire 
crossing. However, optical coherence reflectometry used in a combined OCT and radiofre-
quency ablation device might be able to minimize the risk of perforation and increase the 
crossing potential of the guidewire in CTO PCI [59].
8. Percutaneous intervention of CTO
Complication rates of CTO PCI were traditionally too high to justify these procedures and 
success rates were based predominantly on individual operator skills and annual case 
 volume [60, 61]. A review of the NHLBI Dynamic Registry revealed a decrease of CTO PCI 
attempts from 9.6% in 1997/1998 to 5.7% in 2004 [62]. With the introduction of coronary stents, 
procedural success rates increased substantially and became more consistent across CTO 
studies [63]. In-hospital MACE and 1-year target vessel, revascularization (TVR) rates have 
declined by approximately 50% over the years. Patients with successful recanalization of a 
single-vessel CTO experience a higher 10-year survival rate compared to matched patients 
with a single non-CTO lesion [64].
Among the patients randomized to PCI in the Synergy between PCI with Taxus and Cardiac 
Surgery (SYNTAX) trial, CTO lesions were present in 24% and exhibited a low success rate of 
only 53% [65]. Furthermore, the presence of CTO was the single most common reason for a 
patient to be referred to surgery, and the prevalence of CTO was almost doubled in the CABG 
registry.
A metaanalysis from 18,061 CTO patients treated in dedicated high-volume CTO PCI centers 
and expert operators reported 77% procedural success and a 3.1% risk for MACE [6], whereas 
an analysis from the National Cardiovascular Data Registry revealed CTO PCI in daily prac-
tice to be successful in only 59% [66].
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We have recently seen dramatic improvements in outcomes from a series of single- and mul-
tiple-operator registries with procedural success of up to 98% and MACE rates as low as 
1.7% [67–70]. These results were mainly achieved through constant refinement of interven-
tional techniques and dedicated interventional tools, ongoing knowledge exchange, and the 
development of standardized treatment algorithms. Most of the current CTO crossing tech-
niques were made possible by the introduction of microcatheters and specialized guidewires. 
Further advances in CTO PCI will be dependent on the interplay between the development of 
recanalization techniques and interventional armamentarium.
8.1. Indications for CTO PCI
Indications for CTO PCI are in principle identical to the standard PCI of non-CTO lesions 
and are based on detailed clinical assessments (Figure 1). High procedural success rates in 
conjunction with low complication rates improve risk/benefit ratio and are paramount for the 
acceptance and dissemination of CTO PCI. Successful CTO recanalization has the ability to 
relieve angina [71], reduce ischemia [41] and the need for CABG [72], improve exercise toler-
ance [73], electrical stability [74], left ventricular function [44], and tolerance of future ACS 
[13, 75], and possibly survival [76, 77] with a similar risk compared to regular PCI of non-CTO 
lesions [3]. Table 1 summarizes the rationale for CTO PCI.
Asymptomatic patients with CTO demand additional ischemia and viability testing. 
As described above, cardiac MRI has the ability to quantify viable myocardium and detect 
transmural involvement and therefore may assist in patient selection and procedural plan-
ning [78].
Based on small retrospective studies and on expert consensus, American and European 
guidelines recommend CTO PCI in patients with evidence for substantial ischemia in a cor-
responding myocardial territory when performed by an experienced operator in case of 
adequate clinical indications and suitable anatomy with a class-IIa, evidence level B recom-
mendation [79, 80].
Angina relief [71]
Reduction of ischemia [41]
Improvement of exercise tolerance [73]
Improvement of left ventricular function [44]
Improvement electric stability [74]
Improved tolerance of future ACS events [75]
Reduced need for CABG [72]
Increased long-term survival in successful versus failed cases [76, 77]
Table 1. Rationale for CTO PCI [226].
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8.2. Radial access for CTO PCI
Radial access is feasible for contralateral injections in CTO PCI but may be challenging 
when microcatheters and techniques with additional equipment are used [81, 82]. However, 
based on the availability of sheathless-guiding catheters with a larger interventional lumen, 
the radial approach has become more frequently used for both the antegrade and retrograde 
approach.
8.3. Procedural success in patients with CTO undergoing PCI or CABG
In the early days of interventional cardiology, CTO PCI was associated with very low suc-
cess and relatively high complication rates [83–87]. This leads to a high number of patients 
undergoing surgery, which was also seen in the SYNTAX and the BARI (Bypass Angioplasty 
Revascularization Investigation) trial, where the presence of a CTO was a strong predictor for 
referral to CABG [4, 88].
Procedural failures during CTO are mainly due to the incapacity to pass the lesion with a 
guidewire, followed by failed balloon crossing, the inability to dilate the lesion, or a vessel 
perforation [60, 66, 89–91]. Traditional predictors for CTO PCI failure are increasing age of the 
occlusion, small vessel diameter, presence of calcium or a blunt stump, proximal cap ambigu-
ity, excessive tortuosity, long occlusion length, bridging collaterals, and absent visibility of 
the distal vessel [72, 89, 92–95]. Furthermore, these lesions show a higher mean Multicenter 
CTO Registry of Japan (J-CTO) score and have collaterals that are less likely suitable for the 
retrograde approach [96]. However, additional angiographic features such as multivessel dis-
ease, previous CABG, and side branch at the proximal occlusion point seem not to be predic-
tive for procedural failure with novel guidewire techniques [97].
Over time, with the improvement of both equipment such as microcatheters and dedicated 
guidewires with greater torque response [98] and recanalization techniques such as retro-
grade procedures, safe and effective CTO PCI became possible [60] and most of the prior 
obstacles vanished [99].
Only limited randomized data are available on the outcomes of patients with CTO undergo-
ing CABG [100–102]. CTOs represent a difficult lesion subset also for surgical revasculariza-
tion, thus leading to incomplete revascularization with 31.9% of CTOs referred for CABG 
not being surgically revascularized and 7.5% with occluded bypass grafts after 1 year [103]. 
At least one CTO is found in more than 50% of patients with CABG [1, 104].
In SYNTAX, the presence of a CTO was the strongest independent predictor of incomplete 
revascularization with 51% in the PCI arm and one of the major anatomic predictors for 
referral to CABG [105]. Interestingly, CABG enhances the progression of atherosclerosis 
and increases the risk for new CTOs in native coronary arteries, which itself represents an 
independent predictor of death, MI, and repeat revascularization in these patients [102, 103]. 
Moreover, long-term patency of saphenous vein grafts (SVG) is limited and is significantly 
lower than for second-generation DES (70 vs 90% at 5 years, respectively) [106]. Therefore, 
CABG might only be considered when complete arterial revascularization can be achieved, 
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and given the durability of LIMA-LAD grafts and superior patency of DES over SVGs to LCX 
or RCA, particularly in CTO cases, hybrid revascularization may represent future treatment 
options in selected patients [107, 108].
8.4. Predictive scores in CTO PCI
Scoring systems for CTO PCI are very helpful for case selection as well as to predict proce-
dural efficiency and the probability for success and complications [109, 110]. The SYNTAX 
score, indeed, highly depends on the presence and specific features of CTO, with a single CTO 
contributing a substantial 10–15 points but is generally more suitable for diffused triple-vessel 
disease with and without involvement of the left main.
J-CTO [89] and CT-RECTOR [46] scores predict the likelihood of successful guidewire cross-
ing within 30 minutes. The J-CTO score represents a standardized score of difficulty that 
predicts successful guidewire crossing within 30 minutes, is simple, easy to remember, and 
clinically applicable. However, the J-CTO score may be limited in some cases. The CL score 
considers both clinical and angiographic information, predicts success of a first antegrade 
attempt, and may be useful in centers where the retrograde or hybrid approach has not yet 
been implemented [111]. The progress CTO score includes four angiographic characteristics 
and should be applied when using the hybrid approach [112]. A comparison of these three 
scores for predicting success of CTO PCI showed a moderate performance in predicting tech-
nical outcome, with a favor for antegrade procedures [113]. A novel prediction model includ-
ing age, ostial location, and collateral filling was also strongly associated with technical failure 
when using advanced recanalization technologies [70]. The ORA score, however, predicts 
technical failure by both antegrade and retrograde techniques and categorizes difficulty and 
success rate of CTO procedures into four groups.
Finally, the Mehran risk score is most widely used as a classic model for CIN after CTO PCI, 
but it is rather inconvenient in clinical practice because it was established only after contrast 
media exposure [114, 115].
8.5. Stents in CTO PCI
The use of bare-metal stents (BMS) after successful CTO PCI has been proven to be superior 
in terms of immediate angiographic success as well as long-term restenosis and reocclusion 
when compared with balloon angioplasty (POBA) alone [116–120]. DES in comparison to BMS 
shows again a significant reduction in TVR and adverse clinical events [121–126] although a 
trend toward a higher stent thrombosis rate was observed [127–129]. As a consequence, stent 
implantation following successful CTO PCI increased dramatically over time and reached 
nearly 100% at the turn of the millennium [130].
8.6. Bioresorbable vascular scaffolds in CTO
Bioresorbable vascular scaffolds (BVS) have potential long-term benefits compared with DES, 
thus being particularly reasonable in CTO [131]. A first feasibility analysis in 23 patients with 
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selected and simple CTO lesions demonstrated excellent 6-month and 1-year follow-up after 
BVS implantation, but these initial results need to be confirmed in larger studies with further 
long-term follow-up [132].
8.7. Relevance of the target vessel of CTO PCI
Studies have shown the prognostic importance of the anterior wall of the left ventricle 
[133, 134]. In accordance with these findings, successful CTO PCI is associated with an 
improvement in long-term survival as compared to CTO PCI failure in the subpopulation 
of patients with LAD CTO [76] (cohort from 1980 to 2004, overall stent use < 20%, only three 
patients received DES).
Results from a contemporary multinational CTO registry suggest that successful PCI of a 
CTO in only the LAD and the LCX, but not the RCA, is associated with improved long-term 
survival [135]. Over 90% of patients included in this analysis received a stent, mostly DES, 
which likely resulted in higher long-term patency. Due to higher anatomical complexity, the 
LCX is the least commonly attempted target vessel in CTO PCI with a lower rate of procedural 
success and a trend toward higher MACE rates [89, 95, 97, 98, 136, 137].
8.8. CTO and STEMI
Patients presenting with acute STEMI show an incidence of CTO up to 13% and tend to suffer 
poor immediate and long-term prognosis [94, 130, 138–147]. Several trials revealed a concur-
rent CTO in a non-infarct-related artery (non-IRA) as an independent predictor of short- and 
long-term mortality in STEMI patients undergoing primary PCI [148–150]. A metaanalysis of 
seven observational studies including 14,117 patients with a concurrent CTO in a non-IRA 
artery presenting with STEMI found a three-fold increase in mortality in both single- and 
multi-vessel disease cases [75]. Furthermore, concurrent CTO in a non-IRA in MVD was sig-
nificantly associated with residual left ventricular ejection fraction (LVEF) early after STEMI 
and further decrease of LVEF in the first year after the index STEMI [13], and this seems par-
ticularly true for a CTO of the LAD [151].
The acute closure of the donor artery during STEMI leads to extensive myocardial ischemia in 
a two-vessel area with consecutive hemodynamic instability [144, 148, 152–155]. This is even 
more pronounced if the culprit vessel has impaired collateral filling itself [156].
8.9. Complete revascularization in CTO PCI
The most common reason for incomplete revascularization in PCI is the presence of a CTO [157], 
and incomplete revascularization associated with CTO carries a worse outcome and a higher risk 
of death compared with complete revascularization [158, 159]. The potential benefit of success-
ful CTO PCI has been derived from retrospective analyses and mainly includes improvement of 
LVF in preventing heart failure [160], reduction of arrhythmias, and, above all, reduction of mor-
tality, MI, as well as the need for repeating revascularization procedures [161]. Therefore, com-
plete revascularization strategies after the index PCI for STEMI should include CTO procedures.
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The EXPLORE (Evaluating Xience and Left Ventricular Function in Percutaneous Coronary 
Intervention on Occlusions After ST-Elevation Myocardial Infarction) trial was the first ran-
domized controlled trial evaluating whether patients with STEMI and concurrent CTO in a 
non-IRA benefit from additional CTO PCI shortly after primary PCI [151]. In agreement with 
earlier registry studies, EXPLORE reported a survival benefit only for successful CTO PCI of 
the LAD but not for the RCA or LCX [76, 135].
Migliorini et al. studied 330 high surgical risk patients undergoing PCI for unprotected left 
main disease (ULMD) with more than one-third having at least one CTO [162] and found 
the presence of a concurrent CTO of the RCA in patients undergoing PCI for ULMD to be a 
significant predictor for mortality. In contrast to other studies, CTO of both LAD and LCX 
were not found predictive of worse outcomes. The fact that RCA CTO were attempted less 
frequently (51%) than CTO of the other two main coronary arteries (79%) may explain the 
prognostic impact of the RCA in this study.
In the SYNTAX trial, incomplete revascularization was associated with a significant increase 
in 4-year mortality [105]. The presence of a CTO was less likely to result in complete revas-
cularization in both the PCI and CABG arms and was the strongest independent predictor of 
incomplete revascularization in the PCI arm. The very low rate of complete revascularization 
in the PCI arm (34.3%) compared with the CABG arm (64.8%) was mostly related to CTO PCI 
failure in approximately 50%.
8.10. Restenosis after CTO PCI
Long subintimally placed stents may attribute to a higher restenosis rate. They are typically 
seen with the STAR technique [163] and are more frequent after retrograde wire crossing 
[164]. DES are consistently superior over BMS. Second-generation everolimus-eluting stents 
have lower rates of restenosis after CTO PCI compared with first-generation DES [165], and 
PCI of a CTO in stent restenosis shows generally a high success rate with good long-term 
results [166]. Many studies on restenosis after CTO PCI, however, did not have angiographic 
follow-up despite the fact that reocclusion can be completely silent after CTO PCI [121, 122, 
129, 164, 165, 167–173].
9. Specialized CTO recanalization techniques
As described above, CTO remains one of the most difficult subsets in interventional treat-
ment of CAD patients and is generally considered to be challenging during a revasculariza-
tion approach because of high procedural complexity. With the introduction of innovative 
catheter-based devices and the development of standardized treatment algorithms, CTO PCI 
has been increasingly performed with high success and low complication rates. At this, a thor-
ough assessment of specific lesion-related factors and the use of a systematic step-up interven-
tional strategy contribute to lower periprocedural comorbidities with better  post-procedural 
outcome [98, 174].
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Currently, there are three major CTO crossing techniques: (1) antegrade wire escalation 
(AWE), (2) antegrade dissection re-entry (ADR), and (3) retrograde procedures including ret-
rograde wire escalation (RWE) and retrograde dissection re-entry (RDR).
9.1. Antegrade techniques
9.1.1. Antegrade wire escalation
AWE is the most widely used CTO crossing technique and is appropriate for short occlusions 
or extended ones where a remaining microchannel is expected [174, 175]. However, AWE was 
found to be unlikely successful in complex lesions [176].
Classical antegrade techniques are single wire-based starting with a soft hydrophilic wire 
seeking for microchannels, followed by gradual escalation to harder and stiffer wires [98]. 
Higher penetrating force is needed in more fibrous and calcified lesions, and nonhydro-
philic wires represent a good alternative for loose tissue or intimal plaque tracking [98]. 
However, strong angulated lesions with evidence of bridging collaterals usually exhibit a 
higher risk of perforation, and the use of stiffer wires with a higher tip load and penetration 
force in these cases should be cautious [174]. Furthermore, gradually increasing wire tip 
load with the goal of finding the safest wire has the potential to decrease risk of perforation 
[98].
When performing AWE, the guidewire is advanced to the occlusion point, advanced across 
the lesion, and followed by the microcatheter that adds support and increases penetration 
power, allows wire exchange or wire reshaping, and finally maintains position once the lesion 
is crossed to place an extra support wire for balloon dilatation and stenting [69]. In case of 
subintimal positioning, the wire is guided back into the true lumen by different techniques or 
withdrawn and redirected if it leaves the target vessel [174].
Parallel wire techniques facilitate re-entry of the true lumen by leaving the first wire in the 
subintimal space to seal the false track and act as a marker. Continued manipulation of this 
wire close to the distal cap should be avoided as it can cause subintimal hematoma that com-
presses the distal true lumen and complicate re-entry. A second penetrating wire is therefore 
introduced using a microcatheter, and an attempt is made at redirection into the true lumen. 
Double lumen microcatheters contain both a monorail and an OTW port and are ideally 
suited for parallel wiring techniques.
Seesaw wiring involves simultaneous use of two microcatheters and wires and has the advan-
tage of avoiding the need for complex exchange of OTW microcatheters. Also, wires can be 
reshaped and their roles switched promptly.
9.1.2. Antegrade dissection re-entry
ADR techniques make intentional use of a dissection plane in the subintimal space for cross-
ing CTOs. This concept was first introduced by Antonio Colombo who originally advanced 
a knuckled guidewire through the subintimal space until it spontaneously re-entered into 
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the distal true lumen (subintimal tracking and re-entry technique) [177]. However, high 
 restenosis and reocclusion rates are found in extensive subintimally stented lesions [165]. 
Therefore, ADR should not be enforced as a first-line technique. The mini-STAR was pre-
sented as bail-out technique and includes limited subintimal tracking distances [178] associ-
ated with improved outcomes [179]. Dedicated subintimal tracking and re-entry devices such 
as the CrossBoss catheter and Stingray balloon allow controlled re-entry into the distal true 
lumen from the subintimal space [180, 181].
9.2. Retrograde techniques
As complexity rises, advanced techniques are needed to improve procedural success. The 
retrograde approach has the ability to significantly increase success rates, particularly in 
challenging lesions (Table 2) and has become a widely used strategy for CTO PCI dur-
ing recent years [182, 183]. Retrograde crossing of the CTO against the direction of blood 
flow is easier due to the softer, often tapered, and less ambiguous distal cap [15]. These 
properties in contrast to proximal cap morphology during an antegrade approach facilitate 
entering the CTO body with the retrograde guidewire. Additional advantages of the retro-
grade approach are found in the presence of ostial occlusions, unfavorable proximal cap 
(blunt stump, side branch), ambiguity of the occluded segment, poor distal target or distal 
bifurcation [184], and good interventional collaterals in post-CABG patients and in failed 
antegrade cases.
Retrograde CTO PCI can be performed via several collateral pathways including transseptal 
collaterals [185, 186], epicardial collaterals, and SVG [187]. Intraseptal collaterals are nonepi-
cardial vessels, representing a safe route for CTO PCI with a lower risk of rupture, pericar-
dial effusion, and tamponade [188]. The use of microcatheters seems to dramatically reduce 
injury to septal channels during a transseptal retrograde approach [189] and also increases 
the availability of additional routes through tortuous epicardial collaterals [190]. Previously, 
the CART technique with its retrograde approach was limited to the transseptal pathway in 
Ostial occlusion
Unfavorable proximal cap: blunt stump, side branch
Anatomic ambiguity of CTO body
Poor distal target
Distal bifurcation [184]
Good interventional collaterals
Bifurcation at distal cap
Post-CABG patients (retrograde access over bypass)
After failed antegrade attempt
Table 2. Anatomical features favoring the retrograde approach.
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nearly 80% and resulted in more balloon dilatations of the septal channels and a higher per-
foration rate [55, 191].
An in-hospital analysis of procedural and long-term outcomes from the European mul-
ticenter ERCTO registry demonstrated increased numbers of safe and successful retro-
grade  procedures with good long-term outcomes [192]. However, the retrograde approach 
also seems to be independently associated with increased risk of periprocedural com-
plications [193]. IVUS, as described above, can serve as a useful tool for the detection of 
procedure-related vessel damage and subintimal wire tracking to help guide retrograde 
CTO PCI [55].
9.3. The hybrid approach
The hybrid algorithm depicted in Figure 3 represents a combined strategy comprising AWE/
RWE and ADR/RDR techniques (Table 3) [194, 195]. The fundamental principles in hybrid 
procedures require a special mindset and great flexibility in the approach with the ability to 
perceive failure modes early to quickly change strategy and to come back to abandoned strat-
egies, if necessary. Experienced CTO operators aim for efficiency and look for multiple strate-
gies with several options and different techniques. This skillset can be taught and transferred 
with implementation of the hybrid algorithm, ideally in a broader setting with operators of 
different experience levels to improve technical success while maintaining low complication 
rates. The adoption of only a few strategies will limit the patients who can be treated on the 
basis of coronary anatomy [82, 176, 186, 196, 197].
Figure 3. The Hybrid Algorithm. Adapted from Ref. [194].
Interventional Cardiology60
10. Complications
CTO PCI has long been associated with high complication rates with one-third of failed CTO 
PCI attributable to periprocedural complications [96, 183]. The prognostic value of peripro-
cedural MI in non-CTO PCI depends on the extent of irreversible myocardial injury and 
correlates well with the release of cardiac biomarkers [198, 199]. MI after successful CTO 
PCI has been associated with increased long-term mortality and is considered as one of the 
Antegrade
Wire escalation facilitated by antegrade microcatheters [98]
Subintimal tracking and re-entry (STAR) [177]
miniSTAR [178]
Balloon anchoring [227]
Limited antegrade subintimal tracking (LAST) [228]
Subintimal dissection/re-entry strategies (ADR) [196]
Facilitated Antegrade Steering Technique (FAST) [180]
Retrograde
Collateral wire passage (marker wire)
Septal surfing [229]
Microcatheter-assisted retrograde wiring [69]
Rendezvous
Tip-in technique [230]
Kissing wires (antegrade and retrograde wires)
Knuckle wires
controlled antegrade and retrograde tracking and dissection (CART) [231, 191]
Confluent balloon technique [232]
Guide extensions
Externalization
Snaring
Combined antegrade and retrograde techniques
Reverse CART [69]
deflate, retract, and advance into the fenestration technique (DRAFT) [233]
IVUS guiding
Table 3. Contemporary antegrade and retrograde techniques [195].
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most  common yet unrecognized complications in CTO PCI [6]. However, its prognostic value 
remains controversial. Most of the myocardial injuries during CTO PCI are relatively lim-
ited to absent electrocardiographic or echocardiographic changes, and the prognosis in such 
“asymptomatic” patients is much more dependent on the procedural success. However, tech-
niques unique to CTO PCI add to the risk of MI compared with PCI of non-CTO lesions [6, 
200–203]. Hereby, periprocedural MI may occur from shearing off the collateral circulation, 
obstructing or dissecting the proximal epicardial artery or sidebranch[204], collateral vessel 
compromise, donor artery ischemia during balloon anchoring, compression of the lumen by 
subintimal hematoma, thrombus formation, air embolization, or perforation [193].
Altogether, the complexity of the procedure correlates with the risk of periprocedural MI. 
However, its pathophysiological mechanisms are considered to be multifactorial and not fun-
damentally different from non-CTO PCI [201, 205–210].
Classic safety equipment should be readily available in the catheter laboratory and includes 
transthoracic echo, coils, pericardial drains, and stent grafts. New techniques usually provoke 
new complications asking for specific treatment solutions [211, 212].
11. Interventional armamentarium
Technical difficulties during CTO PCI with high procedural failure rates have been lately 
overcome by introducing a growing number of innovative devices that address a very specific 
problem associated within a particular recanalization algorithm [213]. In order to perform 
CTO PCI successfully, it is paramount to know the availability, utilization properties, and 
technical limitations of each individual hardware.
11.1. Guidewires
Guidewires provide the primary and most critical piece of equipment to successfully perform 
CTO PCI. Innovation and repetitive iteration over the last 30 years lead to a wide range of pri-
mary, secondary, and tertiary design elements that directly influence endoluminal performance, 
especially in occluded lesions with specific anatomical properties [214]. At this, there is an indi-
vidual demand for a specific wire spectrum during CTO recanalization with specific lesion 
characteristics, whereas in non-CTO PCI, usually one work horse wire serves for everything.
Tip load is measured in grams and defined by the amount of force the guidewire can create at 
the tip, whereas penetration power is the ability to penetrate the tissue and is defined by the 
ratio of tip load over tip area. CTO guidewires with tapered tips exhibit higher penetration 
power than their nontapered counterparts with equal tip load. Additional penetration force 
is generated with a microcatheter, in small vessels or tight lesions proximal to the tip, and by 
lateral support of the coating.
The coating, generally applied to the surface of the guidewire, can be a polymer jacket, a 
hydrophilic or hydrophobic film, or any combination of the above, and modifies pushability, 
trackability, and steerability.
Interventional Cardiology62
The introduction of composite core dual coil guidewires with a second coil layer twisted in 
opposite turns around the first coil dramatically improved torque transmission and steering 
capabilities in tortuous arteries and opened new frontiers in CTO PCI, especially in hard calci-
fied tortuous vessels.
Flexibility defines how well a guidewire advances around a sharp corner and is characterized 
by the core tapering length and the coil structure at the distal end of the wire. Gradually, 
 long-tapered wires better follow tortuous, sharp-bended vessels but provide less support to 
other gear following. Shorter tapers, however, provide greater support near the tip but exhibit 
also greater tendency to prolaps.
Spring coils generally affect not only support, trackability, and visibility but also have an 
impact on the guidewire diameter and provide tactile feedback.
11.2. Microcatheters
After successful crossing of the CTO lesion with a dedicated CTO guidewire, the micro-
catheter is advanced past the occlusion to exchange the guidewire for a work horse wire 
or extra support guidewire in heavily calcified lesions of tortuous vessels, followed by bal-
loon angioplasty and stenting. Special trapping techniques for hydrophilic wires and flushing 
techniques for non-hydrophilic wires are used to exchange individual microcatheters. Over 
the years, several microcatheters have been developed to dilate microchannels, to improve 
back-up support and torque transmission, and to facilitate guidewire exchange or reshaping. 
Furthermore, wire directability and penetration capacity can be maximized with the com-
bined use of a microcatheter and a stiff-tapered penetration wire [215].
11.3. Angioplasty balloons
Very low profile angioplasty balloons with hydrophilic coating are available to cross tight 
and calcified lesions. However, with increasing use of retrograde and subintimal tracking 
techniques, these small balloons become less crucial to successfully cross the lesion.
11.4. Additional tools
In addition to the aforementioned devices, dedicated re-entry systems such as the Stingray 
balloon have been invented facilitating selected cases through controlled antegrade sub-
intimal re-entry [216, 217]. Other novel applications and techniques are constantly being 
developed [218]. In complex cases, adjunctive use of several sophisticated devices may be 
cumbersome [219].
12. Clinical outcome data
Successful CTO PCI and improvement in survival strongly depend on the target ves-
sel. So far, only CTO PCI of the LAD seems to be associated with improved long-term 
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 survival [76]. From a 20-year experience of CTO PCI, Suero et al. reported improved pro-
cedural and long-term outcome [64] which was in line with more recent data from Aziz 
et al. who revealed CTO failure as an independent predictor of death and a higher rate of 
subsequent CABG (3.2 vs. 21.7%, P < 0.001) [140]. The result from Aziz could be confirmed 
by Mehran et al. (long-term clinical outcomes in 1791 patients who underwent PCI of 1852 
CTOs) and Jones et al. (6996 patients underwent elective PCI for stable angina with 11.9% 
for CTO) who both demonstrated an association of successful CTO revascularization with 
reduced long-term cardiac mortality (all-cause mortality: 17.2% for unsuccessful CTO PCI 
vs 4.5% for successful CTO PCI [220], and 8.6 vs. 6.0%, [221] respectively) and the need for 
CABG surgery at a 5-year follow-up (with similar rates as Suero et al.) [220, 221]. Other 
studies, however, did not show a mortality benefit for successful CTO PCI compared with 
failed PCI [222].
In the Swedish Coronary Angiography and Angioplasty Registry (SCAAR), CTO was asso-
ciated with increased overall mortality and considered to be the highest risk in patients 
under 60 years of age. Furthermore, the risk attributable to CTO was highest in the STEMI 
subgroup, and the authors reported no interaction between CTO and either diabetes or 
sex [223].
A metaanalysis of CTO PCI on clinical outcomes including 13 observational studies and 7288 
patients with a weighted average follow-up of 6 years [77] showed a significant lower mortal-
ity, residual or recurrent angina, and subsequently CABG rate after successful CTO PCI.
Another meta-analysis of procedural effects on clinical outcomes after CTO PCI in over 12,000 
patients with a mean follow-up of 3.7 ± 2.1 years [224] showed a PCI success rate of 71.2% with 
a significant reduction of all-cause mortality and MACE in this group. Nevertheless, success-
ful CTO PCI was associated with a higher risk of TVR but reduction of subsequent CABG. 
Recently, Christakopoulos et al. reported from the largest metaanalysis, including over 28,000 
patients [225] as well an improvement of clinical outcomes (mortality, MI, CABG, stroke, and 
angina but not TVR) after successful PCI, regardless of the revascularization technique (bal-
loon angioplasty, BMS, or DES).
13. Ongoing randomized CTO trials
Most of the clinical outcome data of CTO interventions derives from retrospective analy-
ses and registry data. Prospective randomized controlled trials such as the DECISION-
CTO trial (Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in 
Patients with Chronic Total Occlusion) and the EURO-CTO trial (European Study on the 
Utilization of Revascularization versus Optimal Medical Therapy for the Treatment of 
Chronic Total Coronary Occlusions) are largely missing and eagerly awaited. Other trials 
such as the REVASC trial investigate left ventricular function before and after successful 
CTO PCI.
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Abbreviations
ACS Acute coronary syndrome
ADR Antegrade dissection and re-entry
AMI Acute myocardial infarction
AWE Antegrade wire escalation
BARI Bypass Angioplasty Revascularization Investigation
BMS Bare-metal stent
BVS Bioresorbable vascular scaffold
CABG Coronary aortic bypass graft
CAD Coronary artery disease
CART Controlled antegrade and retrograde tracking and dissection
CART Controlled antegrade and retrograde subintimal tracking
CC Collateral connections
CFI Collateral flow index
CT-RECTOR CT-Registry of chronic total occlusion revascularization
CTA Coronary computed tomography angiography
CTO Chronic total occlusion
CVP Central venous pressure
DECISION-CTO Drug-eluting stent implantation versus optimal medical treatment in 
patients with chronic total occlusion
DES Drug-eluting stent
EURO-CTO European study on the utilization of revascularization versus optimal 
medical therapy for the treatment of chronic total coronary occlusions
FFRD Fractional flow reserve in the donor artery
HF Heart failure
IRA Infarct related artery
ISR In-stent restenosis
IVUS Intravascular ultrasound
J-CTO Multicenter CTO Registry of Japan
LAD Left anterior descending artery
LAST Limited antegrade subintimal tracking
LAST Limited antegrade subintimal tracking
LCX Left circumflex artery
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LVEF Left ventricular ejection fraction
MACE Major adverse cardiac event
MI Myocardial infarction
MRI Magnetic resonance imaging
MSCT Multislice computed tomography
MVD Multi-vessel disease
NHLBI National Heart, Lung, and Blood Institute
OAT Open artery trial
OCT Optical coherence tomography
OMT Optimal medical therapy
PCI Percutaneous coronary intervention
POBA Plain old balloon angioplasty
RCA Right coronary artery
RCT Randomized controlled trial
RDR Retrograde dissection and re-entry
REVASC Recovery of left ventricular function in chronic total occluded 
coronary arteries
RWE Retrograde wire escalation
SCAAR Swedish Coronary Angiography and Angioplasty Registry
STAR Subintimal Tracking and Re-entry
STEMI ST-segment elevation myocardial infarction
STRAW Subintimal TRAnscatheter withdrawal technique
SVG Saphenous vein grafts
SYNTAX Synergy Between PCI with Taxus and Cardiac Surgery
TIMI Thrombolysis In myocardial infarction
TVR Target vessel revascularization
ULMD Unprotected left main disease
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